In the study, piperine was shown to downregulate MMP-9 expression by inhibiting PKCα/ERK1/2 and NF-κB/AP-1 pathways in a PMA (phorbol-12-myristate-13-acetate)-induced cancer model in vitro. Here, PRKCA is linked to cancer.